Effects of lanthanum carbonate and calcium carbonate on fibroblast growth factor 23 and hepcidin levels in chronic hemodialysis patients

被引：1
|
作者：
Yu-Ming Chang
Shih-Ching Tsai
Chih-Chung Shiao
Hung-Hsiang Liou
Chuan-Lan Yang
Nai-Yu Tung
Kua-Sui Hsu
I-Ling Chen
Mei-Chyn Liu
Jsun-Liang Kao
Rong-Na Jhen
Ya-Ting Huang
机构：
[1] Department Saint Mary’s Hospital Luodong,Division of Nephrology, of Internal Medicine
[2] Hsin-Jen Hospital,Division of Nephrology, Department of Internal Medicine
[3] Saint Mary’s Hospital Luodong,Department of Nursing
[4] Saint Mary’s Hospital Luodong,Nutrition Room
[5] Hsin-Ren Clinics,Dialysis Center
来源：
Clinical and Experimental Nephrology | 2017年 / 21卷
关键词：
FGF23; Hemodialysis; Hepcidin; Phosphate binders;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：908 / 916
页数：8
相关论文
共 50 条
  • [31] THE EFFECT OF LANTHANUM CARBONATE ON CALCIPROTEIN PARTICLES IN HEMODIALYSIS PATIENTS
    Nagata, Yudai
    Nakamura, Kimihiko
    Isoyama, Naohito
    Matsumura, Masafumi
    Fujikawa, Koki
    Uchiyama, Koichi
    Kuroo, Makoto
    Matsuyama, Hideyasu
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2016, 31 : 1529 - 1529
  • [32] Serum fibroblast growth factor-23 levels in chronic haemodialysis patients
    Ibrahim, Salwa
    Rashed, Laila
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2009, 41 (01) : 163 - 169
  • [33] Serum fibroblast growth factor-23 levels in chronic haemodialysis patients
    Salwa Ibrahim
    Laila Rashed
    International Urology and Nephrology, 2009, 41 : 163 - 169
  • [34] Lanthanum carbonate versus calcium carbonate: Effect on parathyroid hormone (PTH) levels.
    Hutchison, A
    Webster, I
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 : 205A - 205A
  • [35] Serum Intact Fibroblast Growth Factor 23 Levels Are Negatively Associated with Bone Mineral Density in Chronic Hemodialysis Patients
    Lee, Wen-Teng
    Fang, Yu-Wei
    Chen, Mingchih
    Liou, Hung-Hsiang
    Lee, Chung-Jen
    Tsai, Ming-Hsien
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (04)
  • [36] CALCIUM-CARBONATE FOR TREATMENT OF HYPERPHOSPHATEMIA IN CHRONIC-HEMODIALYSIS PATIENTS
    KISS, D
    BATTEGAY, M
    MEIER, C
    LYRER, A
    SCHWEIZERISCHE MEDIZINISCHE WOCHENSCHRIFT, 1990, 120 (09) : 295 - 298
  • [37] The effects of lanthanum carbonate and calcium carbonate on bone abnormalities in patients with end-stage renal disease
    Freemont, AJ
    Hoyland, JA
    Denton, J
    CLINICAL NEPHROLOGY, 2005, 64 (06) : 428 - 437
  • [38] A multicenter study on the effects of lanthanum carbonate (Fosrenol™) and calcium carbonate on renal bone disease in dialysis patients
    D'Haese, PC
    Spasovski, GB
    Sikole, A
    Hutchison, A
    Freemont, TJ
    Sulkova, S
    Swanepoel, C
    Pejanovic, S
    Djukanovic, L
    Balducci, A
    Coen, G
    Sulowicz, W
    Ferreira, A
    Torres, A
    Curic, S
    Popovic, M
    Dimkovic, N
    De Broe, ME
    KIDNEY INTERNATIONAL, 2003, 63 : S73 - S78
  • [39] Changes in serum fibroblast growth factor 23 during the use of calcium carbonate concurrent with calcitriol in stage 3 CKD patients.
    Lee, Ga Hyeon
    Han, Nayoung
    Hong, Su Hyun
    Kim, Yon Su
    Shin, Whan Gyun
    Oh, Jung Mi
    PHARMACOTHERAPY, 2013, 33 (10): : E284 - E284
  • [40] Additional Reduction in Serum Phosphorus Levels by Pulverized Lanthanum Carbonate Chewable in Hemodialysis Patients
    Yamashita, Tetsuri
    Ogawa, Tetsuya
    Takahashi, Masaki
    Mitsuhashi, Tetsuya
    Shizuku, Junichi
    Takahashi, Naoshi
    Ohba, Takashi
    Miyajima, Sayako
    Kabaya, Takashi
    Otsuka, Kuniaki
    Nitta, Kosaku
    THERAPEUTIC APHERESIS AND DIALYSIS, 2013, 17 : 54 - 59
12345